LEVERAGE CUTTING EDGE TECHNOLOGY
Xennials Therapeutics Inc. is committed to investigate and develop transformative therapies and platforms that improve outcomes for cancer patients in global markets.
OUR MISSION
Committed to investigate, discover, develop and register novel assets utilizing innovative delivery technologies in order to improve outcomes for cancer patients in global markets.
OUR FOCUS
To address unmet needs in treatment paradigms by significantly increasing precise delivery of multiple therapeutics to the target, potentially increasing efficacy and patient compliance, while reducing side effects and costs by introducing novel assets and proprietary platform technologies.
VALUE OF OUR WORK
Xennials Therapeutics Inc. addresses unmet needs in treatment paradigms by significantly increasing efficacy and patient compliance, while reducing side effects and costs by:
Introducing novel assets potentially coupled with proprietary delivery platform technologies: a complex nanoparticle with modified surface capable of carrying novel anti-cancer assets with targeting moieties.
Driven by Xennials Therapeutics Inc. leadership and advisors with decades of scientific, therapeutics, clinical, development, regulatory and commercial expertise.